Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Summary

The purpose of this study is to evaluate the efficacy and safety in patients with non-muscle invasive bladder cancer histologically diagnosed to be stage Ta and G1 or G2 and who were randomized into either an EO9 or placebo group after TURBT.

Timeline

Start

2011-11

Primary completion

2013-04

Completion

2013-04

Outcome

Outcome not reported

Stopped: “Sponsor's decision”

Drugs

Indications